title: Factors predicting non-completion of tuberculosis treatment among HIV-infected patients in Barcelona (1987-1996).
abstract: OBJECTIVE
  To determine the predictive factors of non-completion of tuberculosis (TB) treatment among patients infected with the human immunodeficiency virus (HIV).
  
  
  METHODS
  Between 1987 and 1996, 2201 HIV-infected TB patients were detected by the Barcelona Tuberculosis Prevention and Control Programme. Patients who completed treatment were compared to those who abandoned. Bivariate analysis was made by chi(2) test to compare qualitative variables. Associations were measured by means of odds ratios (OR) with 95% confidence intervals (CI). Variables showing a statistically significant association were analysed at multivariate level by means of a logistic regression model.
  
  
  RESULTS
  Treatment was carried to completion by 1065 patients (48.4%), 289 (13.1%) abandoned, 648 (29.5%) died during treatment, and 142 (6.5%) moved out of the city. Final outcome could not be established in 57 (2.5%). Intravenous drug users (IDU) represented 76.2% of patients. The rate of non-completion between 1987 and 1992 was 26.3% and for 1993-1996 it was 15.1%, a decrease of 42.6%. Living in neighbourhoods of a low socio-economic level (OR 1.61; 95% CI 1.222.13), homelessness (OR 3.56; 95% CI 2.01-6.31), history of TB (OR 1.61; 95% CI 1.12-2.33), and having presented with a current TB episode in 1987-1992 (OR 1.42; 95% CI 1.01-2.00), were risk factors for abandoning TB treatment.
  
  
  CONCLUSIONS
  Social and health factors together influence non-completion of TB treatment in HIV-infected patients, while health interventions can improve treatment completion.
authors.affiliation: Epidemiology Service, Municipal Institute of Public Health of Barcelona, Spain. hgaldos@imsb.bcn.es
authors.forename: H G
authors.initials: HG
authors.lastname: Tangüis
authors.forename: J A
authors.initials: JA
authors.lastname: Caylà
authors.forename: P G
authors.initials: PG
authors.lastname: García de Olalla
authors.forename: J M
authors.initials: JM
authors.lastname: Jansà
authors.forename: M T
authors.initials: MT
authors.lastname: Brugal
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D016022:Case-Control Studies; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000453:epidemiology*; D006801:Humans; D008297:Male; D010352:Patient Dropouts; D012307:Risk Factors; D012959:Socioeconomic Factors; D013030:Spain / Q000453:epidemiology; D014376:Tuberculosis / Q000188:drug therapy* / Q000453:epidemiology
chemical_list: D000995:Antitubercular Agents